Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.
Autor: | Di Lorenzo G, Kreuter A, Di Trolio R, Guarini A, Romano C, Montesarchio V, Brockmeyer NH, De Placido S, Bower M, Dezube BJ |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of investigative dermatology [J Invest Dermatol] 2008 Jun; Vol. 128 (6), pp. 1578-80. Date of Electronic Publication: 2008 Jan 10. |
DOI: | 10.1038/sj.jid.5701215 |
Databáze: | MEDLINE |
Externí odkaz: |